Free Trial

Pandora (PNDORA; Baa2, BBB; S) Roadshow

CONSUMER CYCLICALS

€500m 6Y SLB Mandate, FV MS+100 vs IPT +145a, coming in line.

As flagged last week, retailer curves screen cheap here - H&M & Pandora trade the tight end of the space but that still leaves them in-line with equal-rated Tobacco. We see PVH29s (Baa3/BBB- Double-Pos) at Z+133 as most attractive (issued at +145) but advise those on side-lines to wait out (rough) earnings (4th June). Pandora is attractive vs. peers in the sector on fundamentals; higher growth & much higher margins balanced by somewhat smaller scale, single brand reliance & low penetration in large EM jewellery markets (China <0.5% market share, India 0%)


  • Pandora is a ~€4b in sales jewellery retailer that says it aims to be largest brand in the "accessible luxury market" - not to be confused with Kering/Gucci "aspiration luxury" exposure (in the middle of the two). Latter has suffered recently (see Kering notes) while former should be more resilient through downturns & benefit from consumers trading down.
  • Re. exposure it is Asia & China light; 50% Europe 34% NA & 8% Latin America are largest 3 regions. It is targeting growth into India, Japan & Korea (20% of global Jewellery market). See Q1 notes for country exposure but US heavy is takeaway.
  • Fundamentals are strong; 25% EBIT margin, cash conversion on that at 78% with organic growth recently in HSD & expected to continue there. For comparison fellow Scandi co, H&M (NR/BBB) - which 28s trade in-line with - runs MSD operating margin with strong cash conversion but flat to LSD growth. Pandora is targeting 25% EBIT margin this year (reporting same as CY) & 26-27% by 2026.
  • On ratings; very stable. S&P and Moody's assumptions look below consensus on headline revenue (they see MSD to HSD growth over next 2 years vs. consensus at ~10% avg.) & S&P's explicit EBTIDA target of DKK9.8b is about 5% below consensus. FCF assumptions from both look similarly conservative and are not that relevant given size of equity pay-outs/BS squared away.
  • On BS: 1.3x levered in Q1 on net debt at DKK12.6b (€1.4b) including DKK4b (€560m) in lease liabilities & DKK900m (€120m) in cash. Liquidity isn't a issue on access to revolvers, target leverage is 1.2x to end this year & has a ceiling of 1.5x. Little net supply on this deal; €500m (DKK 3.7b) in proceeds to pay down DKK2b (~€270m) loan due next year. It issued its first bond (a 5Y/28 €500m) last year for similar loan paydowns. That line will be the only debt (outside leases) left on the balance sheet.
  • Step-ups (on redemption price): This is a SLB line and it's tied to 2 performance targets 1) to reduce scope 1,2 & 3 emissions by 36% (vs. 2019 levels) by 2028 - it had got to 27% in FY23 - triggers redemption price step up of 60bps and 2) at least 44% women in leadership by 2028 (was at 34% in FY23) with redemption price step up of 40bps. Step ups/triggers can occur on each individually.
  • Some Asides: On ESG it's showcasing some strong ratings and in '23 it switched to using only recycled silver and gold in production. It has exposure to commodities; it says 10% silver/gold price increase impacts operating margin by 0.7%. Manufacturing facilities concentrated in EM countries, Thailand and Vietnam.

1Q Results; https://marketnews.com/pandora-pandora2-28s-baa2-b...

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.